• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Chronic Disease

Low incidence and high clearance of oral HPV infections in men

bys25qthea
July 7, 2013
in Chronic Disease, Infectious Disease, Public Health
Reading Time: 3 mins read
Reduced HPV vaccine doses may be adequate
Share on FacebookShare on Twitter

Image: PD

1. The incidence of an oncogenic-type oral HPV infection acquired in one year was 1.7%. 

2. Of men with oncogenic-type oral HPV associated with oropharyngeal cancer, more than half were cleared of infection within one year, with a median infection duration of 6.3 months. 

Evidence Rating Level: 2 (Good) 

Study Rundown: This prospective study found that the incidence of oncogenic-type oral HPV infections acquired in one year was relatively low (1.7%) and that more than half of the newly acquired infections were cleared within 1 year. Oral HPV infections (specifically type 16) are considered largely responsible for the recent increase in incidence of oropharyngeal cancers, specifically in men. This is one of the first large-scale studies to examine the natural history of oral HPV infections in men.

To date this is the largest prospective study to evaluate this research question. However, a minority of patients (39.9%) were eligible for inclusion in analysis, as the majority of patients only had 1-2 follow-up visits, creating the opportunity for selection bias and limiting researchers’ ability to accurately assess and characterize clearance. Additionally, the study was primarily funded by Merck Sharp & Dohme, the producers of the leading HPV vaccine, though the funders had no role in study design or data collection. The findings of this work contribute to understanding of the natural history of oral HPV infection and serve as a basis for further, more focused investigations into the acquisition, persistence, and epidemiology of oral HPV.

RELATED REPORTS

Post-traumatic stress disorder is associated with increased risk of mild cognitive impairment and dementia among United States Veterans

Center of Disease Control layoffs raise alarm over surveillance and preparedness

New York confirms first locally acquired chikungunya case in six years

Click to read the study in The Lancet

Click to read an accompanying editorial in The Lancet

Relevant Reading: Uptodate: Human papillomavirus associated head and neck cancer

In-Depth [prospective cohort study]: Researchers used a subset of participants from the HPV Infection in Men (HIM) study, a multinational cohort study of 4,072 healthy men ages 18-70 begun in 2005, to estimate the incidence and clearance of oral HPV infections. Men were included in this sub-analysis if they provided 2 or more oral rinse-and-gargle samples with valid HPV results and completed at least 1 follow-up visit questionnaire. Oral samples were genotyped for specific HPV infections, grouped into oncogenic and non-oncogenic), and linear array methods were used to calculate incidence and clearance.

Of the 4,072 men in the study, 1626 men (39.9%) were included in the analysis with a median follow-up of 12.7 months (IQR 12.1-14.7). Within the first 12 months, 4.4% (n=115, 95% CI=3.5-5.6) of men in the study acquired an oral HPV infection, 53 (12-month incidence of 1.7%) of which were oncogenic types. Smoking and cohabiting or being unmarried were significantly associated with increased incidence of oral oncogenic HPV infections. Age, country of origin, lifetime number of sexual partners, and recent oral sex were not associated with increased incidence. The median infection duration was 6.9 months (6.2-9.3) for any HPV type and 6.3 months (6.0-9.9) for oncogenic HPV types. More than half of new infections were cleared within 1 year.

By Maren Shapiro and Leah Hawkins, MD, MPH

More from this author: IUD contraception equally safe in teenagers as in older women, Black men less likely to receive follow-up for elevated prostate cancer marker, PSA, Intake of fish fatty acids associated with lower risk of breast cancer, Lower prevalence of HPV infection in teen girls after vaccine introduction

© 2013 2minutemedicine.com. All rights reserved. No works may be reproduced without written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT. Content is produced in accordance with fair use copyrights solely and strictly for the purpose of teaching, news and criticism. No benefit, monetary or otherwise, is realized by any participants or the owner of this domain. 

Tags: healthhpvoral HPVSTDSTIviruswarts
Previous Post

Severe endometriosis associated with poor IVF outcomes

Next Post

Half of parents aware of CT radiation cancer risk

RelatedReports

Chronic Disease

Post-traumatic stress disorder is associated with increased risk of mild cognitive impairment and dementia among United States Veterans

October 2, 2026
Adding trained interventionists to primary care results in weight loss
All Specialties

Center of Disease Control layoffs raise alarm over surveillance and preparedness

September 4, 2026
Intrauterine Zika virus infection associated with significant fetal brain abnormalities
All Specialties

New York confirms first locally acquired chikungunya case in six years

September 4, 2026
The Scan by 2 Minute Medicine®:  Ultra-Trail du Mont-Blanc, Taylor Swift, NBA rookie Chet Holmgren and Magic Mushrooms!
Infectious Disease

The Scan by 2 Minute Medicine®: FDA clears Alzheimer’s blood test, WHO warns of antibiotic resistance, New York confirms chikungunya case, and CDC layoffs raise concern

October 21, 2025
Next Post
Half of parents aware of CT radiation cancer risk

Half of parents aware of CT radiation cancer risk

Prenatal alcohol-induced developmental delay is dose and time dependent

Prenatal alcohol-induced developmental delay is dose and time dependent

A quarter of youths with assault injury own a gun

A quarter of youths with assault injury own a gun

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Low-dose radiotherapy may be effective as a short-term therapeutic option in knee osteoarthritis
  • Physician edits to artificial intelligence (AI)-generated messages to patients were associated with different response time burdens
  • Male sex is associated with higher mortality among patients with hepatocellular carcinoma
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.